Twin Health raises Rs 1 billion to combat chronic metabolic diseases.
Twin Health, based in the United States and Chennai, has announced Rs 1000 crore in Series C funding as it expands its presence in India and the United States.
The funds will be used to help scale Whole Body Digital Twin technology, which will be used to reverse and prevent chronic metabolic diseases such as type 2 diabetes.
The Whole Body Digital Twin advises patients and doctors on nutrition, sleep, activity, and meditative breathing in order to safely reverse and prevent a variety of chronic metabolic diseases such as type 2 diabetes, cardiovascular disease, and liver disease.
“As a scientist, I am impressed by the ongoing RCT results and the cutting edge Whole Body Digital Twin technology,” said Prof Shashank Joshi, Chief Scientist at Twin Health, Consultant Endocrinologist Lilavati Hospital Mumbai, and President of the Indian Academy of Diabetes. It has now been scientifically proven that Type 2 Diabetes can be reversed by healing the root cause of chronic metabolic diseases such as type 2 diabetes through highly personalised data-driven recommendations to doctors and patients.”